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ABSTRACT
Introduction: Vaccination is among the most important areas of progress in the worldwide history of
public health. However, a crescent wave of anti-vaccine groups has grown in Western countries,
especially in Italy, in the last two decades. Our aim was to evaluate adult’s hesitancy and knowledge
about vaccines and related diseases in Trentino-Alto Adige -the Italian region with the lowest vaccina-
tion coverages.
Methods: We administered self-answered structured questionnaires in three malls in the Trentino
province in June 2019. We collected demographic data and information on knowledge about vaccines,
infectious diseases and attitude in seeking health information. We utilized a descriptive and multivariate
analysis to investigate factors associated with vaccine hesitancy.
Results: We collected 567 questionnaires, 18% of the people interviewed were hesitant toward vaccina-
tion and 16% were against mandatory vaccination. In the multivariate analysis a poor level of information,
being younger than 60 years and being against compulsory vaccination were associated with vaccine
hesitancy. Regarding information about vaccines, 76.5% of the people relied on physicians, and/or 49%
navigated the internet, while social media are used by 16% of the study population. Though 41.5%
searched information on official sites, only 14% knew the website VaccinarSì and 4.7% had visited it.
Discussion: Compared to a previous study conducted in all of Italy except Trentino Alto Adige, the level
of vaccination hesitancy was higher. It is important to utilize health professionals, the internet and
especially social media to spread scientific information about vaccination.
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Vaccination is among the most important areas of progress in
the worldwide history of public health.1 Nevertheless,
a growing number of anti-vaccine groups has spread in
Western European countries, especially in Italy2 in the last
two decades. In 2016, a 67-country survey conducted by the
Vaccine Confidence Project (VCP) found that the European
region had lower confidence in the safety of vaccines than
other world regions.3 Moreover, the European region
accounted for seven of the ten countries with the lowest levels
of safety-based confidence issues3 four of which (France,
Greece, Slovenia, and Italy) are in the European Union
(EU).4 In 2017 there was a significant outbreak of measles in
Italy, due to a large pool of measles-susceptible people result-
ing from a low rate of measles vaccination. Measles vaccine
rates were very low in the years following its introduction in
Italy in 1976 and this has led to large vaccination gaps among
adolescents and young adults, and a constantly increasing
median age of reported cases.5
A clear inverse correlation between measles incidence and
vaccine coverage can be observed in the years following the
introduction of a single-antigen measles vaccine in 1976.5,6
The MMR vaccine was phased into Italy in its current
formulation in the early 1990 s, followed in 1999 by the
recommendation that a second vaccine dose be administered
in regions with over 80% coverage for the first dose. In 2003,
in an attempt to eliminate endemic measles and rubella trans-
mission by 2007, the Italian Ministry of Health launched the
National Plan of Measles and Congenital Rubella Elimination
(PNEMoRC), recommending the introduction of two MMR
doses in all Italian regions with the target of achieving 95%
vaccine coverage (http://www.salute.gov.it/imgs/C_17_pubbli
cazioni_730_allegato.pdf, 2003). Although vaccination rates
uptake for the first dose improved after implementation of
the first national elimination plan in 2003, reaching 90.6% in
2010, the target of 95% was never reached. In the following
years, MMR vaccine coverage continued to increase among
the Italian population, with single-dose coverage reaching
a maximum of 90.6% in 2010. Worryingly, MMR coverage,
however, started to decline steadily after 2010, reaching
a minimum of 85.2% in 2015.7
Administratively, the Italian republic is divided into 19
regions and two autonomous provinces, Trentino and
Bolzano,8 forming the region of Trentino-Alto Adige. Each
province has legislative power and is not subject to the med-
ical policies9 of the region. In Italy only diphtheria, tetanus,
poliomyelitis and hepatitis B vaccines were mandatory until
CONTACT Bénédicte Melot melotb@gmail.com Department of Prevention, Agency of Health of Trento, Italy
Supplemental data for this article can be accessed online at https://doi.org/10.1080/21645515.2020.1763085.
HUMAN VACCINES & IMMUNOTHERAPEUTICS
https://doi.org/10.1080/21645515.2020.1763085
© 2020 Taylor & Francis Group, LLC
2008.10 At that time Veneto became the « test province » to
try to eliminate any mandatory vaccines and attempt to keep
high levels of vaccination coverage through appropriate infor-
mation campaigns for the population.10 This attempt unfor-
tunately lead to terrifying decline in immunization levels not
only in Veneto but also in other regions including Trentino-
Alto Adige where the vaccination coverage had already been
the lowest.9 It can be assumed that the political measures
adopted in Veneto influenced the public opinion about
immunization requirements also within other Italian regions.
Consequently, in 2017 the National Prevention Vaccination
Plan was enacted making 10 vaccines mandatory in all of
Italy11 to respect the international guidelines for vaccination
published by the WHO12 and give the chance to every child
born in Italy to grow without any infectious disease preven-
table by vaccines. This was the so called Lorenzin decree. This
sudden turnaround in national immunization policy has
increased controversy over the social and ethical aspects of
vaccination and cannot ensure long-term success.10
Unfortunately, the political climate in Italy favored skepti-
cism: in 2015 the Five Star Movement party, one of the most
powerful political parties in Italy, proposed a law against
vaccinations, citing “the link between vaccinations and speci-
fic illnesses such as leukemia, poisoning, inflammation,
immunosuppression, inheritable genetic mutations, cancer,
autism and allergies.”
Again, during the campaign for March 2018’s general
election, the hard-right Lega and the eclectic Five Star
Movement (M5 s) both doggedly opposed the vaccination
policy, repeating pseudoscientific objections to MMR vaccina-
tions. And when these two parties formed a new government
in June, new interior minister called the set of ten vaccina-
tions “useless, in some cases dangerous if not harmful,” with-
out specifying the grounds his views were based upon. As
a result, the small but virulent anti-vaccine movement has
been buoyed by the rise to power of a populist coalition
skeptical about vaccinations.
This is the reason why reliable scientific sources of infor-
mation within the internet and particularly social networks
have been strengthened. Among the proposed initiatives, the
VaccinarSì portal was created in 2013 by the Italian Society of
Hygiene13,14 and continued its development by creating spe-
cific regional websites. Its objective is to improve access for
the general population to quality affordable scientific infor-
mation for the general public. It details the benefits and risks
of each vaccination, the infectious diseases against which they
protect, answers to parents’ frequent questions about the
vaccination, side effects, schedule of information meetings,
etc. It also has a Facebook page, Youtube, Twitter and
a blog. An analysis of the use of the national portal, conducted
6 years after its creation (Bordin et al 2019, being published
on Annali di Igiene) revealed a rather satisfying popularity of
the website (it is very frequented), mainly among health
professionals, but a continuous gradual decline of user’s
level of engagement with the portal (people stay always less
time on the website, visit less pages and tend to immediately
visit another website after this one).
The aim of our study was to determine the knowledge,
attitudes and practices regarding vaccination of Trentino-Alto
Adige inhabitants (as it is the region with the lowest vaccine
rates), two years after the change of vaccination policy11 and
six years after the creation of the VaccinarSì national website,
and to identify risk factors for immunization hesitancy. Our
ultimate intention was to adapt the content and the presenta-
tion of the new VaccinarSì provincial portal [available at the
URL: www.vaccinarsintrentino.org] to the survey results.
Material and methods
Study design and population
We devised a cross-sectional and questionnaire based descrip-
tive study on Knowledge Attitudes and Practices (KAP) about
vaccination. The questionnaires were administered in three
shopping centers: in Trento, Riva del Garda and Rovereto.
These settings were chosen because they are highly frequented
public places. The study population consisted of adults over
18 years, residing in the Trentino-Alto Adige region and
visiting one of the three shopping centers between June 25,
2019 and July 5, 2019. All adults who were in the shopping
centers at the time of the survey and walked close to our stand
at the main entrance were therefore selected and invited to
respond to our survey. We explained that we were working to
understand the opinion of the population of Trentino about
vaccination. They were asked if they would answer our anon-
ymous questionnaire.
Sampling
In order to estimate vaccination hesitancy with a precision of
3%, under the assumption that about 15% of respondents
were going to be hesitant,15 the sample size required for our
survey was 544 persons.
Questionnaire
The questionnaire was a computerized, anonymous, standar-
dized and self-administered electronic case report form
(eCRF). It was provided through dedicated tablets and the
data was collected directly on the survey software. It consisted
of 43 closed or semi-closed questions, focused, written in
simple language, not judgmental or taking position. In the
case of no-response to a question, an alert appeared to remind
the respondent to answer the question, otherwise it was
impossible to go further. When a question was not under-
stood, medical staff were available for clarification. For those
people who could not dedicate the time needed to complete
the entire questionnaire, we collected a minimum of usable
information consisting of the first 6 questions (hereinafter
referred to as “short version”). The entire questionnaire is
reported in Appendix. At the end of the questionnaire com-
pletion, the participants were given a leaflet containing vac-
cine information, the Italian vaccination schedule and a link
to the “VaccinarSì” website to get more information. Prior to
administration, the questionnaire had been tested on 30 peo-
ple randomly selected, in order to evaluate the intelligibility of
questions and instructions as well as to test the time needed
for its completion.
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Variables collected
To choose the most relevant variables to collect we based our
questions on tools proposed by the SAGE Working group on
Vaccine Hesitancy.16 The short version of the questionnaire
only included information on sex, age, attitude toward vac-
cines and vaccination requirements, whether or not he/she
would accept vaccinations if not mandatory and if he/she
knew the VaccinarSì website. The long questionnaire was
divided into seven sections: one for socio-demographic data
(number of young or very young children, marital status,
province of residence, country of origin, professional cate-
gory, level of education); a section on attitudes and 5 sections
on knowledge and practices related to vaccines, the related
diseases and the sources of information used by respondents.
Face validity was guaranteed by our qualitative evaluation
at the moment of the completion of the questionnaire.17 To
provide content validity, we made sure that the items or tests
covered all the main reasons of hesitation by comparing them
to the SAGE recommendations;16 that the items covered these
different aspects proportionally; that the instrument did not
contain irrelevant tests or items thanks to the pilot study.
An overall knowledge score was then created based on the
correct answers to the questions 25, 27 to 30 and 33 to 37
assigning 1 point per correct answer. The knowledge was
regarded good, intermediate or bad for overall scores between
8 to 10, 5–8 and 0–5 respectively (see Table 4).
Data analysis
The variable of interest in our study was the hesitation toward
vaccines.
It usually refers to refused or delayed vaccination in
a context of vaccines availability.18 Because of the difficulty
in collecting this information in the framework of our study,
we asked participants to self- define their attitude about
vaccines, by answering the question “what kind of attitude
do you think you have about vaccines? “. Those responding
“against” or “doubtful” or “not sufficiently informed” were
considered to be hesitant about vaccination.
The explanatory variables that we collected were age, sex,
education attainment, employment, number of children, geo-
graphic origin, living environment (urban or rural), and atti-
tudes, knowledge, and seeking behavior regarding vaccines.
We investigated the knowledge of the VaccinarSì website and
the satisfaction with it. We performed a descriptive analysis of
the characteristics of the whole studied population and an
analysis according to their hesitation regarding vaccination.
The variable “age” was transformed into a categorial variable
using categories based on quartiles (18–33, 34–43, 44–59, 60
and upper). We used a t-Student’s test to compare the quan-
titative variables and a Chi2 or Fisher test for the qualitative
variables. In all the analyzes, a p value of 0.05 was considered
statistically significant.
A multivariate logistic regression analysis was then per-
formed. We included in the multivariate models the explana-
tory variables whose p-value in the univariate analysis was
equal to or lower than 0.2. Through a manual descending
procedure, we determined which covariates include in the
final model. This procedure allowed us to better understand
possible modifiers of effect or confusion factors. We did not
stratify. We used the Hosmer and Lemeshow adequacy tests
and the deviance residue method to check the adequacy of our
model. The statistical analyzes were performed by the RStudio
Version 1.1.463 software. All tests were two sided.
Results
We collected a total of 567 questionnaires including 396
(70%) entirely completed and 171 (30%) short version con-
sisting of the first six questions (the 30 adults of the pilot
study were not taken into account for this analysis). The
response rate for both kinds of questionnaires was 100%
(people could not pass a question because they had an alert
blocking them from going on to the next question). The data
collected through the short version of the questionnaire
according to vaccination hesitancy are reported in Table 1.
Overall, 106 (18.7%) persons have been defined hesitant toward
vaccination and the prevalence of participants completing the
entire questionnaire did not differ significantly between hesitant
people and non hesitants (respectively 69% and 70%, p = .8).
There was not any significant difference in regard to gen-
der or age distribution, with the exception of a significantly
higher proportion of under-60 years old among hesitant par-
ticipants (respectively 84.9% vs 75.5%, p = .03). The average
time spent answering the entire questionnaire was 9 minutes,
and 1 minute to complete the short version, without any
significant difference within the two groups.
Further socio-demographic data of the participants completing
the entire questionnaires are reported in Table 2. No significant
difference emerged with regard to hesitation to vaccination except
for the professional category with a higher proportion of unem-
ployed people among those who were hesitant.
Attitudes
Among hesitant people: 55.7% declared to be suspicious and
33% admitted they lacked information whereas only 11.3%
stated to be completely against vaccination.
As regards attitude toward vaccination, the vast majority of
the respondents thought that vaccines were effective, safe,
without any important side effects and useful for personal or
public health (Table 3). Just a small proportion of hesitants
were convinced that vaccines are not effective (6.8%) but
a considerable proportion of them were convinced that vac-
cines are not useful (32.9%) and have important side effects
(41.1%). Forty-five-point seven percent of hesitants suggested
that vaccines could cause autism, and/or contain mercury
and/or weaken the immune system. The hesitants showed
significantly less confidence in the efficacy, safety, and useful-
ness of vaccines than the non hesitants, and were more often
victims of fake news. People who chose not to vaccinate gave
as a reason the fear of side effects, the mistrust toward the
scientific community, or the absence of obligation.
Concerning attitudes toward the immunization obligation,
16% of all respondents stated to be against and 29.7% declared
they would not have accepted the vaccines or would have
received only a few of them if they were not mandatory for
admission to kindergarten (Table 1).
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Knowledge
Regarding the level of knowledge, significantly more hesitant
people admitted not knowing how a vaccine works; and, although
not significantly, fewer of them would like to know. (Table 4).
The concept of herd immunity was not widely known as
well as the reason for vaccine combinations or co- adminis-
tration. A significantly higher proportion of non-hesitant
people claimed to know the concept of herd immunity, were
aware that severe adverse reactions following food ingestion
are much more likely than that caused by vaccines; and that it
is still important to vaccinate even against now rare diseases.
Less than one third of the study population knew why
many vaccines are co-administered or combined in the same
injection. In this group there was no difference in their atti-
tude of hesitancy. Almost 14% of those who hesitated believed
that combination vaccines were a marketing invention of the
pharmaceutical industry.
Hesitant people had poorer knowledge of alternatives to
fight infectious diseases (hand washing, isolation of sick peo-
ple, antibiotics, immunity acquired by the disease) and were
more likely to use at least one of the following nonscientific
strategies: homeopathy, aromatherapy, living in contact with
nature, physical activity and organic food.
There was no significant difference in the overall knowledge
score as well as in the knowledge of tetanus, measles, whooping
cough (pertussis) within the two groups. The best-known dis-
ease was measle whereas tetanus was known by just slightly
more than a half of the respondents. The match between per-
ceived knowledge level and the level estimated by the score was
62.6%: on third overestimated their level of knowledge.
Practice
The most used sources of information and seeking behavior
are reported in Table 5. Half of the people acquired
information about vaccines on the internet and 16% from
social networks. Those who were hesitant were significantly
less likely to seek information from a physician and more
likely to find information on media and social networks and
to feel that the information already received was contradic-
tory. Claiming to have received clear information was strongly
associated with the absence of hesitation.
The VaccinarSì website was known by 13.9% (79/567) of
the respondents while only 4.7% of them had visited it. Two
people did not find it useful because of the graphic or overly
complicated language (Table 1).
Multivariate analysis
The multivariate logistic regression analysis made it possible
to propose a final model with 9 variables adjusted for age
greater than 60 years, profession, confidence in vaccine effi-
cacy, having already received fake news on immunization, the
opinion on requirements to vaccinate, the refusal to take some
vaccines in the absence of obligation, the knowledge of how
a vaccine works, the knowledge of the prevalence of the
adverse effects of vaccines vs. food borne illness and lack of
awareness of the value of vaccines for diseases that have
become rare (Figure 1). In our model, people over the age
of 60 were less hesitant (p = .03)
Confidence in the efficiency of vaccines and agreement
with the vaccine requirement were decreased by 27% and
28%, respectively, for hesitants compared to non-hesitating
individuals after adjustment for the other variables.
People who were victims of fake news were slightly more likely
to hesitate with an odds ratio of 1.1 after adjusting for the other
variables. Receiving all or only a few of the vaccines in the absence
of obligation and knowledge of the way vaccines work was
decreased by respectively 33%, 22% and 10% among people who
are hesitant compared to non-hesitatant individuals after adjusting
Table 1. Description of variables by vaccination reluctance in the 3 Shopping Centers in Italy, June-July 2019, long questionnaire, n = 567.
Total
(n = 567) Hesitant (n = 106, 18.7%)
Non hesitant
(n = 461, 81.3%)
Variables n % N % n % Crude OR 95% CI P value
Age (years) 0.15
Mean 46.3 44.4 46.7 0.99 0.97–1.00
Standard deviation 15.5 13.8 15.8
Age rank 0.03
18 to 33 157 27.7 32 30.2 125 27.1 1
34 to 43 129 22.8 20 18.9 109 23.6 0.72 0.39–1.33
44 to 59 140 24.7 36 34.0 104 22.6 1.35 0.79–2.33
≥ 60 141 24.9 18 17.0 123 26.7 0.57 0.3–1.07
Sex 0.68
Woman 368 65.0 67 63.2 301 65.3 1
Man 199 35.0 39 36.8 160 34.7 1.1 0.71–1.7
Agreement with obligation < 0.001
No 91 16.0 63 59.4 28 6.1 1
Yes 476 84.0 43 40.6 433 93.9 0.04 0.03–0.08
Would make the vaccination without obligation < 0.001
No 35 6.2 31 29.2 4 0.9 1
Yes all 399 70.4 18 17.0 381 82.6 0.01 0.01–0.02
Only a few ones 133 23.5 57 53.8 76 16.5 0.1 0.03–0.29
Knowledge of the website VaccinarSì 0.57 0.57
No 488 86.1 93 87.7 395 85.7 1
Yes 79 13.9 13 12.3 66 14.3 0.84 0.44–1.58
VaccinarSì ever consulted n = 79 * 0.66 0.66
No 52 65.8 7 53.8 45 65,8 1
Yes 27 34.2 6 46.2 21 34.2 1.23 0.49–3.11
*Numbers for this characteristicsdo not add up to the total number of the study population due to the fact that only 79 people knew the website
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for the other variables in the model. Finally, the fact of not know-
ing whether or not to vaccinate against diseases that have become
rare was also significantly associated with hesitation.
Discussion
Summary of the main results
Our study showed that 18% of respondents were hesitant about
vaccines and a hesitant attitude seems not to have influenced
the completion of the questionnaire. The proportion of hesi-
tants did not vary according to the type of questionnaire.
Multivariate analysis has shown that there is a greater hesitancy
in poorly informed people including those who are uncon-
vinced of vaccine efficacy, have been victims of fake news, do
not know how vaccines work, and those who ignore the risk of
not receiving vaccines including the importance of vaccination
against diseases that have become rare. Likewise, people
younger than 60 years old have greater hesitancy.
Generally, there was a large awareness of vaccine efficacy,
safety and utility. Though a high proportion of people are in
favor of vaccines, a considerable level of uncertainty persists
toward vaccination: 25% of the people believed that vaccines
are unsafe, and almost 50% of the hesitants and 15% of those
favorable were still uncertain about vaccine safety. In addi-
tion, a large proportion of hesitants are doubtful about their
efficacy. This shows the need to spread information about
safety and effectiveness.
Even though our study did not reveal an overall difference
in knowledge score between hesitants and favorable, there was
a remarkable gap between them regarding the knowledge of
the working mechanism of the vaccine.
Despite an insufficient level of knowledge about vaccines in
29.5% of the respondents, more than 50% of them would like
to know more about vaccination revealing the openness to
Public Health information on this topic. Only 13.9% knew the
portal Vaccinarsì and less than 5% had visited it, with no
difference between the hesitants or non hesitants, showing the
need for more promotion of this information Website.
Analysis of literature data
Our study confirms the results of a 2018 Italian national study
which did not include the Trentino-Alto Adige region15 and
two surveys conducted in the south of Italy among
kindergarten.19,20 In the national survey, 15% of adults were




(n = 73, 18.4%)
Non hesitant
(n = 323, 81.5%)
Variables n % n % n % Crude OR 95% CI P value
Province 0.29
Trento 384 97.0 71 97.3 313 97 0.57 0.11–2.98
Other 7 1.7 2 1.7 5 1.5 1
Country of origin 0.69
Africa 13 3.3 4 5.5 9 2.8 1.33 0.26–6.83
America 12 3.0 3 4.1 9 2.8 1 0.17–5.63
Asia 4 1.0 1 1.4 3 0.9 1 0.08–12.5
Italy 351 88.6 1 83.3 290 89.8 0.63 0.2–2
Other European country 16 4.0 4 5.5 12 3.7 1
Living environment 0.34
Urban 114 28.8 17 23.3 97 30.0 1
Rural 131 33.1 29 39.7 103 31.6 1.61 0.84–3.14
Peri-urban 151 38.1 27 37.0 124 38.4 1.24 0.64–2.41
Civil status 0.1
Single or widow 92 23.0 22 30.1 70 21.7 1
Engaged 304 77.0 51 69.9 253 78.3 0.61 0.34–1.1
Parents with
Children < 15 yrs old 166 42.0 28 38.4 138 42.7 0.83 0.5–1.4 0.49
Children < 3 yrs old 66 16.6 11 16.7 55 17.0 0.86 0.43–1.75 0.68
Pregnant 0.13
No 389 98.3 70 95.9 319 98.8 1
Yes 7 1.7 3 4.1 4 1.2 3.42 0.75–15.6
Educational attainment 0.23
PhD/Master degree 32 8.1 3 4.1 29 9.0 1
Bachelor 106 26.8 19 26.0 87 26.9 2.11 0.58–7.65
High school graduation 199 50.3 43 58.9 156 48.3 2.66 0.77–9.17
PSAT * 55 13.9 8 11.0 47 14.6 1.65 0.4–6.71
Occupation < 0.001
Agriculture 8 2.0 1 1.4 7 2.2 1
Artisan 7 1.8 3 4.1 4 1.2 5.25 0.4–68.95
Housewife 24 6.1 2 2.7 22 6.8 0.64 0.05–8.12
Merchant 11 2.8 2 2.7 9 2.8 1.56 0.12–20.8
Manager 12 3.0 2 2.7 10 3.1 1.4 0.11–18.6
Unemployed 14 3.5 9 12.3 5 1.5 12.6 1.2–133.9
Employee 91 23.0 19 26.0 72 22.3 1.85 0.21–15.9
Teacher 29 7.3 3 4.1 26 8.0 0.81 0.07–9.0
Free-lance 26 6.6 6 8.2 20 6.2 2.1 0.2–20.64
Worker 42 10.6 8 11.0 34 10.5 1.65 0.18–15.3
Retired 51 12.9 1 1.4 50 15.5 0.14 0.01–2.5
Health professional 28 7.1 7 9.6 21 6.5 2.33 0.24–22.4
Student 16 4.0 1 1.4 15 4.6 0.47 0.03–8.6
* Preliminary National Merit Scholarship Qualifying Test
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hesitant, a little lower rate than in our study. Actually,
a higher level of hesitation in our study is consistent with
lower coverage rates. The causes of hesitation mentioned were
similar to ours: mainly safety issues related to vaccines and
contradictory or negative opinions from health professionals.
Although in our study the lack of perceived clarity of infor-
mation was much greater among hesitants (84% vs. 44%), it
was not associated with hesitation in the multivariate analysis.
People over 60 years of age were significantly less likely to
hesitate in our study, possibly due to age-related long experi-
ence of no serious side effects following immunization, an
understanding of the high risks of vaccine-preventable dis-
eases due to personal memory or because of less exposure to
fake news due to less internet and social network use. Another
possible hypothesis is that they are no longer exposed to the
vaccination obligation. The obligation applies to young chil-
dren and therefore calls for the self-determination by their
parents which are most frequently aged between 20 and
45 years old as shown in the two recent studies conducted
in the south of Italy.19,20
However, one of the factors associated with hesitation in the
population of our study was opposition to vaccination require-
ments. The reasons given were loss of self-determination (67%),
“Big Pharma” conspiracy theory (44%) and the injustice of
school exclusion. As shown in the report on vaccinations in
Trentino in 2018,6 since the introduction of the immunization
obligation in 2017, delays in vaccination have been reversed and
coverage has been attained creating herd immunity (approxi-
mately 95% of 36-month-old children are up to date). Other
studies have already shown a clear positive impact of the obliga-
tion for immunization coverage, however its impact on vaccine
hesitancy is much more uncertain.21 Thus, the importance of
accompanying these obligations with information on the collec-
tive benefits of vaccination and the concept of herd immunity.
However, opposition to obligation is not the only pitfall to
vaccine confidence. In fact, 30% of the people surveyed in our
study said they would not have received all the vaccines offered
in the absence of obligation. Reasons given for non-vaccination
included no obligation, fear of side effects, or lack of confidence
in Western medicine. The determinants of hesitation are a mix
of demographic, structural, social, and behavioral factors. In the
multivariate analysis we have shown that a low level of infor-
mation was associated with hesitation. In fact, the score of
knowledge was low for 30% of the surveyed population; and
there was a lack of correlation between the level of estimated
knowledge and the actual level, with an overestimation of the
level of knowledge in 37.4% of cases.
A low level of knowledge is the gateway for the influence of
“scientific denialists”22 These use theories of conspiracy, false
experts (Montanari in Italy), selectivity of references
(Wakefied for autism), impossible expectations (100% of vac-
cines should have 0% side effects) and a false logic (syllo-
gisms) to convince their listeners of inaccurate reasoning
against vaccines.23
In addition, some studies have shown a link between a low level
of education and vaccine hesitancy.24,25 Others, including one in
the Veneto in 2011,26,27 showed the opposite. In the Italian
national study and in our study no influence of sex or level of
education was shown on vaccine hesitancy. In contrast, the lack of
employment, which is often correlated with a lower level of educa-
tion, was identified as possibly associated with hesitation in our
study (p = .06). Another explanation is the link between populism
and unemployment.28 The last years of Italian politics are char-
acterized by the rise of populist parties shown by the victory of the
coalition between the Five stars movement and the Liga in the
election of 2018.
Several studies have shown a highly significant positive
association between the proportion of people in a country
who voted for populist parties and who believe that vaccines
are not important.29,30
Vaccine education must therefore be carried out in all
sections of the population regardless of sex and socio-
cultural level. Indeed, given what is at stake in vaccine con-
fidence and immunization programs, health officials and




(n = 73, 18.4%)
Non hesitant
(n = 323, 81.5%)
Variables n % n % n % Crude OR 95% CI P value
Confidence with efficiency < 0.001
Yes 347 87.6 35 47.9 312 96.6 1
No 6 1.5 5 6.8 1 0.3 44.5 5.0–392.4
Does not know 43 10.9 33 45.2 10 3.1 29.42 13.3–64.7
Confidence with safety < 0.001
Yes 290 73.2 17 24.7 272 84.2 0.01 0–0.05
No 83 5.8 19 26.0 4 1.2 1
Does not know 23 21.0 36 49.3 47 14.6 0.16 0.05–0.52
Confidence with utility < 0.001
Yes 363 91.7 49 67.1 314 97.2 0.06 0.03–0.13
No 33 8.3 24 32.9 9 2.8 1
Conviction of adverse effects < 0.001
Important 45 11.4 30 41.1 15 4.6 1
Light 226 57.1 26 35.6 200 61.9 0.06 0.03–0.14
Does not know 72 18.2 16 21.9 56 17.3 0.14 0.06–0.33
Without adverse effects 53 13.4 1 1.4 52 16.1 0.01 0–0.08
Fake news victim* < 0.001
No 215 54.3 12 16.4 203 62.8 1
Yes 181 45.7 61 83.6 120 37.2 8.6 4.4–16.6
* have been influenced by false messages such as: link between autism and vaccination, presence of mercury in vaccines, risk of weakening of the immune system by
vaccines
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institutions – as well as NGOs and international agencies –
should demonstrate utmost transparency, prudence, and
accountability. This is necessary if they are to address the
populist refrain of a corrupt establishment and if they are to
restore the all-important element of trust that will doubtless
continue to play a decisive role in the future of immunization.
The advice of the health professionals and the guidelines of
the health authorities are the sources of acceptance of the
most cited vaccines.31–34 A huge initiative called Wellcome
global monitor, the world’s largest study into how people
around the world think and feel about science and major
health challenges completed in 2018 showed that trust in
vaccines tends to be strongly linked to trust in scientists and
medical professionals; people who have strong trust in scien-
tists overall are more trusting of vaccines, and vice versa.35
Another initiative called the vaccine confidence project aims
at monitoring public confidence in immunization programs
worldwide.36 They published a large survey of 28 European
Union member states showing that Countries whose family
Medical doctors are more confident in the importance, safety,
and effectiveness of vaccines are more likely to have higher
confidence among the public.4
In our study, over 75% of respondents said they inquired
about vaccines with a doctor as in previous Italian studies.15,37
Hence the importance of educating health professionals
regarding how to respond to anti-vax and hesitant claims.
However, we must not ignore the influence of the web38
and particularly social networks on the attitude of the popula-
tion toward vaccines.14,23 The hesitants were much more
likely to use social networks than those who are non-
hesitating to find information about vaccines (57.5% vs.
25.5%) without being able to identify a causal link in the
multivariate model adjusted on the other variables.
In our study, 41.4% of respondents were informed by
official websites but only 14% were familiar with the
VaccinarSì site; and less than 5% had already consulted it,




(n = 73, 18.4%)
Non hesitant
(n = 323, 81.6%)
Variables n % n % n % Crude OR 95% CI P value
Knows how a vaccine works < 0.001
No 73 18.4 26 35.6 47 14.6 1
Yes 323 81.6 47 64.4 276 85.4 0.31 0.17–0.54
Would like to know more 0.427
Maybe 92 23.2 22 30.2 70 21.7 1
No, not interested 38 9.6 7 9.6 31 9.6 0.72 0.28–1.86
No, do not need 41 10.4 8 12.0 33 10.2 0.77 0.31–1.91
Yes 225 56.8 36 49.3 189 58.5 0.61 0.33–1.1
Knows what herd immunity is 0.02
Maybe 72 18.2 16 21.9 56 17.3 1
No 114 28.8 29 39.7 85 26.3 1.19 0.6–2.4
Yes 210 53.0 28 38.4 182 56.3 0.54 0.27–1.07
Adverse effects from food vs vaccine < 0.001
Food 284 71.7 38 52.1 246 76.2 1
Vaccine 17 4.3 7 9.6 10 3.1 4.53 1.6–12.62
Same frequency 15 3.8 9 12.3 6 1.9 9.71 3.27–28.8
Does not know 80 20.2 19 26.0 61 18.9 2.02 1.09–3.74
Vaccine for rare diseases < 0.001
No 31 7.8 16 21.9 15 4.6 1
Does not know 29 7.3 15 20.5 14 4.4 1 0.36–2.76
Yes 336 84.8 42 57.5 294 91.0 0.13 0.06–0.29
Why several vaccines at the same time 0.55
Maybe 75 18.9 11 15.1 64 19.8 1
No 198 50.0 40 54.8 158 48.9 1.47 0.71–3.05
Yes 123 31.1 22 30.1 101 31.5 1.27 0.57–2.79
Knowledge of alternatives to vaccines 0.04
Yes 340 85.9 57 78.1 283 87.6 0.5
Knowledge of tetanus 0.23
Yes 231 58.3 38 52.1 193 59.8 0.74
Knowledge of measles 0.27
Yes 292 73.7 50 68.5 242 74.9 0.73 0.42–1.27
Knowledge of pertussis 0.12
Yes 243 61.4 39 53.4 204 63.2 0.67 0.41–1.14
Knowledge of available vaccines° 0.47
Yes 185 50.0 17 46.5 103 50.8 0.84 0.53–1.35
Knowledge score* 0.43
Good 124 31.3 24 32.9 100 31.0 1
Bad 117 29.5 25 34.2 92 28.5 3.19 1.63–6.24
Intermediate 155 39.1 24 32.9 131 40.5 1.34 0.65–2.76
Concordance real level/estimated level 0.09
No 148 37.4 21 28.8 127 39.3 1
Yes 248 62.6 52 71.2 196 60.7 1.6 0.92–2.79
° The knowledge of available vaccines was considered as the acknowledgment of at least 6 existing vaccines and no more than one non-existing vaccine
* The knowledge score was created with the answers to the following questions: “Do you know how a vaccine works?” “Do you know what herd immunity is?” “Are
the side effects of vaccines more or less common than those due to food?” “Do you think it is useful to vaccinate against diseases we don’t hear more about
anymore?” “Do you know why several vaccines are made at the same time?” “What are the alternatives or supplements to vaccines to prevent infectious diseases in
general?” “Do you know 2 symptoms or complications of tetanus? Measles? Whooping cough? For which of the following diseases are vaccines?”. If the score was
greater than 8 out of 10, the knowledge was considered good, between 5 and 7 as intermediate, and less than 5 insufficient.
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which is similar to that of the Sicilian study in 2015 where
only 6% of adults knew of the VaccinarSì site. The use of the
VaccinarSì website by the general population should then be
reinforced.
Perspectives
According to our study, several Public health interventions
could probably be effective in this population of Trentino. In
fact, education concerning how a vaccine works could cer-
tainly improve confidence about vaccines. Half of the popula-
tion in our study would like to know more about vaccines and
hesitants are more likely not to know how vaccines work.
Discussing the obligation is another possible working path
as many hesitants do not agree with the obligation.
Hesitants are more likely to search for information on vac-
cines on social networks. This allows hesitant groups to form
regardless of geography or politics as a result of web based
brief messages, images and narratives.14,24 We should con-
sider targeting this way of communication for scientific
information.
Strengths and limitations
Our study has several strengths: the way of collecting data was
inclusive. The shopping center recruitment allowed us
a representative sample, as we interviewed people of all ages
and from all social backgrounds. The proportion of hesitants
and non hesitants did not vary according to the type of
questionnaire. As a result, we are rather confident that the
data collected through the long version of the questionnaire is
representative of the entire study population. This is the first
study of this kind in the region which gives originality to our
work and quick spin-offs with suggested improvements to the




(n = 73, 18.4%)
Non hesitant
(n = 323, 81.6%)
Variables n % n % n % Crude OR 95% CI P value
Information by doctor 0.04
Yes 303 76.5 49 67.1 254 78.6 0.55 0.32–0.97
Information on media 0.04
Yes 185 46.7 42 57.5 143 44.3 1.71 1.02–2.8
Information on internet 0.34
Yes 197 49.7 40 54.8 157 48.6 1.28 0.77–2.13
Information on official sites 0.64
Yes 164 41.4 32 43.8 132 40.9 1.13 0.68–1.9
Information on social network < 0.001
Yes 63 15.9 23 31.5 40 12.4 3.25 1.8–5.9
Clear information < 0.001
Contradictory information 48 12.1 21 28.8 27 8.4 1
No 94 23.7 28 38.4 66 20.4 0.55 0.3–1.22
Does not know 60 15.2 12 16.4 48 14.9 0.32 0.14–0.7
Yes 194 49.0 12 16.4 182 56.3 0.08 0.04–0.2
Recent information 0.12
No 203 51.1 38 52.1 165 51.1 1
Does not know 23 5.8 8 11.0 15 4.6 2.32 0.92–5.9
Yes 170 43.1 27 37.0 143 44.3 0.8 0.48–1.4
Figure 1. Final multivariate model of characteristics associated with vaccine hesitancy among adults interviewed in 3 shopping centers in Italy, June-July 2019,
n = 396.
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layout of the website. A national study was done in 2016, but
it did not include this region, which is the one with the lowest
vaccination rate in the country.
Our study nevertheless had some biases. First, the chosen
study design exposed us to a selection bias due to the settings
chosen. Shopping centers could be less frequented by certain
groups of people because of different consumption habits,
reduced purchasing power or disabilities. In addition, due to
location, we relied on self- definition of vaccine hesitancy,
instead of the standard definition used in the literature (i.e.
based on the respect of the immunization schedule) which
may have selected another population. Moreover, we selected
those who agreed to take the time to answer a questionnaire
on vaccination, which might have excluded the most refrac-
tory ones. Also, our data might have been affected by an
information bias, since self-administered questionnaires can
include memory bias, recall bias, and social desirability bias.
Nevertheless, we avoided as much as possible errors caused by
misinterpretation providing the help of investigators if
needed. We also avoided the omission or inaccuracy of
a response by using an electronic case report which did not
allow respondents to proceed if they failed to answer
a question. We attempted to overcome confusion bias by
performing a multivariate logistic regression model allowing
an adjustment to the other explanatory variables.
Unfortunately, we could not stratify on age or sex because
of insufficient number of respondents.
Conclusion
Our survey measured a relatively high rate of vaccine hesi-
tancy in the population of Trentino in 2019 (18%) and iden-
tified factors associated with hesitation including lack of
knowledge, misinformation and being opposed to the
obligation.
Our approach was well accepted by the surveyed popula-
tion generating both interest and questions. Many of the
people were grateful for this effort, which allowed them to
increase their knowledge about vaccines and infectious dis-
eases. They asked for information leaflets and the correct
answers to the questions.
In order to counteract fake news about vaccinations it
seems urgent to better inform the doctors but also the general
population through developing innovative marketing and
communication strategies. Given their undeniable spread
and their growing influence on the beliefs of the population,
some scientific profiles on social networks (Facebook,
Instagram and Youtube) should be implemented, using inter-
esting contents and redirecting to the official sites such as
VaccinarSì. In a practical guide for the public to use in
response to the anti-vax39 movement, the WHO in 2017
precisely explained the mechanisms behind the strong resis-
tance of anti-vax or hesitants to scientific information. Indeed,
several biases underlie misunderstanding: the bias of negativ-
ity (the audience trusts more negative information than posi-
tive and the credibility of the information than the reliability
of the source), the bias of narration (the rational thinking of
the audience is easily distorted by a narrative), the confirma-
tion bias (the audience focuses on messages that confirm their
perspective), and the Backfire effect (risk of creating a false
belief by attempting to demystify it). These biases are mental
shortcuts influencing individuals when making decisions in
a complex world.40
It is essential to openly explain the reasons behind the
vaccination obligation, to share proof of vaccine effectiveness,
and dismantle the fake news regarding autism, fears regarding
the immune system and the presence of heavy metals. This
should be done by using short communications, more narra-
tives of previous hesitants, and counter arguments to the anti-
vax community. To support these innovative scientific com-
munication strategies, it is necessary to carry out repeated
media campaigns with the general population, such as during
our survey in shopping centers; but also with healthcare
professionals, in the schools, through newspapers, the internet
and social networks.
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